elix design
  • ABOUT US
  • BUSINESS
  • CASE STUDIES
  • RESEARCH
  • NEWS
  • CAREERS
  • CONTACT
  • ABOUT US
  • BUSINESS
  • CASE STUDIES
  • RESEARCH
  • NEWS
  • CAREERS
  • CONTACT
JP
EN

NEWS

news
Elix, Inc. | News
  • All Categories

  • INFORMATION
  • NEWS RELEASE
  • LIBRARY
    • Jun 20, 2022 Information
      The Chemical Daily published an article about the launch of Elix Discovery™, Elix’s AI drug discovery platform. (June 17, 2022)
    • Jun 17, 2022 Information
      Nikkan Yakugyo and AnswersNews published articles about the launch of Elix Discovery™, Elix’s AI drug discovery platform
    • May 31, 2022 Information
      Elix’s CEO Shinya Yuki has been appointed as the secretary of the Society of Computational Toxicology
    • May 17, 2022 Information
      Elix CEO Shinya’s interview was published in The Pharma Letter
    • Apr 12, 2022 Information
      Elix will exhibit the booth at “Pharma IT & Digital Health Expo 2022”
    • Apr 1, 2022 Information
      Joint research with SHIONOGI & CO., LTD. for verification of practical retrosynthetic analysis was introduced in BioWorld and The Pharma Letter
    • Mar 28, 2022 Information
      Elix CEO Shinya Yuki will give an online lecture on this Friday, April 1st 2022 from 19:00 JST
    • Mar 25, 2022 News Release
      Elix, Inc. begins collaboration with Shionogi & Co., Ltd. on Elix Synthesize (AI Drug Discovery Module) for verification of practical retrosynthetic analysis
    • Mar 18, 2022 Information
      Joint research with SHIONOGI & CO., LTD. was introduced in Nikkei Xtech (March 18, 2022)
    • Feb 28, 2022 Information
      Joint research with SHIONOGI & CO., LTD. was introduced in The Chemical Daily (February 28, 2022)
    1 2 … 8 NEXT

CONTACT

Thank you for your interest in our company.
Please complete the form below to get in touch with us
and help improve your business in drug disocvery.

CONTACT

© 2022 Elix, Inc.

日本語